Business Context and Reporting Period
This Form 6-K filing by Arbe Robotics Ltd. covers the month of November 2024. The report details the commencement and pricing of an underwritten public offering (the "Offering") initiated on November 1, 2024, with an anticipated closing date of November 4, 2024.
Key Financial Metrics and Offering Details
The Offering consists of the following securities sold at a public offer price of $1.82 per share (or $1.8199 for Pre-Funded Warrants):
- Ordinary Shares: 4,293,957 shares.
- Pre-Funded Warrants: Warrants to purchase up to 3,956,043 Ordinary Shares at an exercise price of $0.0001.
- Tranche A Warrants: Warrants to purchase up to 8,250,000 Ordinary Shares at an exercise price of $2.35, expiring November 4, 2029.
- Tranche B Warrants: Warrants to purchase up to 8,250,000 Ordinary Shares at an exercise price of $1.82, with a complex expiration trigger based on a definitive supply agreement with a European OEM and specific trading volume/price metrics, or November 4, 2027.
Proceeds and Costs:
- Net Proceeds: Approximately $14.1 million (excluding potential proceeds from warrant exercises).
- Potential Additional Proceeds: Approximately $34.4 million if Tranche A and Tranche B Warrants are fully exercised on a cash basis.
- Underwriting Fees: 6.0% of aggregate gross proceeds plus $125,000 in expense reimbursement. An additional 6.0% cash fee applies to proceeds from the exercise of Tranche A and B Warrants.
Use of Proceeds: Working capital and general corporate purposes.
Note: The filing does not provide specific revenue, profit, cash flow, margin, or debt figures for the company's operations.
Material Changes and Lock-Up Agreements
In connection with the Offering, the Company's directors and officers entered into lock-up agreements prohibiting the sale or disposition of Ordinary Shares or convertible securities for 90 days following the Closing. Additionally, the Company agreed not to issue or announce the issuance of any Ordinary Shares or convertible securities for 90 days following the Closing, subject to certain exceptions.
Outlook, Risks, and Contingencies
Warrant Exercise Contingencies: The Tranche B Warrants contain a "Triggering Event" that could accelerate their expiration. This event requires the Company to announce a definitive supply agreement with a European automotive OEM for a minimum of 500,000 radar chipsets, followed by specific VWAP and trading volume thresholds within a defined period.
Risks: No assurance is given that the Tranche A or Tranche B Warrants will be exercised. The filing notes that the description of the Underwriting Agreement and warrant terms is qualified by reference to the full text of the exhibits.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received after all expenses.
- Monitor the Company's progress toward securing a definitive supply agreement with a European OEM, as this impacts the Tranche B Warrant expiration.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) and Warrant forms (Exhibits 4.1, 4.2, 4.3) for detailed terms and limitations.
- Track the 90-day lock-up period expiration for directors and officers to assess potential future selling pressure.
- Confirm the effective status of the registration statement for the "Saleable Shares" underlying the Tranche B Warrants.